Overview
Status
Active
Registry date
2018-04-20
Share capital
5,000.00 PLN
Registered address
ul. Kazimierza Wielkiego 1, 50-077 Wrocław, Poland
Financials
Only balance sheet data (assets and liabilities) is available. The income statement (P&L) is not available in the source filing for this period.
Revenue history
Filing timeliness
No financial statement for 2023 – the filing deadline has passed. 5 of 5 financial statements were filed late (the longest delay 1229 days for 2018).
- 2023not filed
- 202222/04/2024
- 202125/11/2022
- 202025/11/2022
- 201925/11/2022
- 201825/11/2022
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Authorized Representatives
Piotr Jacek Smagała – Management Board Member
Manner of representation
In the case of a one-person management board, the company is represented by the sole member of the management board or a commercial proxy independently. In the case of a multi-member management board, the company is represented by two members of the management board acting jointly.
Supervisory board
Jakub Andrzej Bis – Supervisory Board Member
Bartłomiej Bednarz – Supervisory Board Member
Maciej Król – Supervisory Board Member
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Jakub Andrzej Bisage 38 | 50 | $675.31 | 50% |
Piotr Jacek Smagałaage 58 | 50 | $675.31 | 50% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
| Publication date | Event | |
|---|---|---|
| Sep 6, 2021 | Dissolution without liquidation opened |
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Vitrotest Europesp. z o.o. | $233,350.77 | vitrotest.pl | ||
| Frontline BiosciencesS.A. | $219,186.29 | frontlinebiosciences.com | ||
| VASA Therapeuticssp. z o.o. | $216,535.01 | vasatherapeutics.com | ||
| MultiqureS.A. | $149,394.35 | purebiologics.com | ||
| Luna Laboratorysp. z o.o. | $61,894.23 | lunalab.pl | ||
| GenomtecS.A. | $54,746.36 | genomtec.com | ||
| MAP Your Dna Spólka z Ograniczoną Odpowiedzialnościąsp. z o.o. | $7,283.38 | mapyourdna.eu | ||
| Centrum Transferu Technologii Meditransfer Iitdsp. z o.o. | $228.56 | iitd.pan.wroc.pl | ||
| BioencaS.A. | $0.00 | bioenca.pl | ||
| Olenasp. z o.o. | – | imsolutions.pl |
FAQ
The main business activity of EJS focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on April 20, 2018.
The headquarters is located at: ul. Kazimierza Wielkiego 1, 50-077 Wrocław.
The management board consists of: Piotr Jacek Smagała (Member of the Management Board).
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2022 to December 31, 2022.
Last updated: 2026-04-06